HHS investigates FDA official over conflict-of-interest claim

08/12/2009 | Wall Street Journal, The

The HHS Office of Inspector General launched an investigation in response to a conflict-of-interest complaint by Amphastar Pharmaceuticals against Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research. The issue involves a scientific paper written by Woodcock and scientists at Momenta Pharmaceuticals while Amphastar and Momenta were awaiting FDA approval for competing versions of blood thinner Lovenox.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX